ProsTac Softgel
Natural health product licensed in Canada
- Other names
- ICON PROSTAC, SH-Prostaid softgels, Wellness Prostac Softgel
- Licence holder
- Viva Pharmaceutical Inc.
- NPN or DIN-HM
- 80059331
- Status
- Active licence
- Licence date
- 27 March 2015
- Revision date
- 18 September 2025
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 23.64 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Taraxacum officinale Source : Taraxacum officinale - Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 120 milligramme | 30 milligramme | Not calculated |
| Zinc Source : Oxyde de zinc | 7.88 milligramme | 23,640 µg |
| Serenoa repens Source : Serenoa repens - fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 800 milligramme Potency : 90 Pour cent Fatty acids | 80 milligramme | Not calculated |
| Arctostaphylos uva-ursi Source : Arctostaphylos uva-ursi - feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 100 milligramme | 25 milligramme | Not calculated |
| Cucurbita pepo Source : Cucurbita pepo - Graine | 300 milligramme | Not calculated |
| psi,psi-carotène Source : Lycopène | 10 milligramme | Not calculated |
| Urtica dioica Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 250 milligramme | 50 milligramme | Not calculated |
Non-medicinal ingredients
Dioxyde de titane, Lécithine, Gélatine, Eau purifiée, Bleu FD&C n° 1, Glycérine, Cire d'abeille jaune, Rouge FD&C N° 40, Graine de citrouille, Jaune FD&C No. 5, Huile de fève de soja
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of oleic acid. Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia. Provides antioxidants for the maintenance of good health. Helps to support prostate health. Used in Herbal Medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia (BPH). Helps in connective tissue formation. Helps to maintain healthy skin. Helps the body to metabolize carbohydrates, proteins and fats. Helps to maintain immune function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80059331
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.